Pivotal Research Issues a Buy Rating on Herbalife

By Austin Angelo

Pivotal Research analyst Timothy Ramey assigned a Buy rating to Herbalife (NYSE: HLF) yesterday and set a price target of $120. The company’s shares closed yesterday at $69.21.

According to TipRanks.com, Ramey is a 4-star analyst with an average return of 7.0% and a 63.0% success rate. Ramey covers the Consumer Goods sector, focusing on stocks such as Constellation Brands Inc, Omega Protein Corp, and Post Holdings Inc.

Herbalife has an analyst consensus of Moderate Buy, with a price target consensus of $79.50.

Herbalife’s market cap is currently $6.24B and has a P/E ratio of 14.52. The company has a book value ratio of 31.2138.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Herbalife Ltd. is a global nutrition company. It offers science-based weight management products, nutritional supplements and personal care products intended to support a healthy lifestyle. The company operates through the following geographical segments: North America; Mexico; South & Central America; Europe, Middle East and Africa; Asia Pacific and China.